Effect of cardiac rehabilitation on vascular function and glycemic condition in diabetic patients with Ischemic Heart disease

Effect of cardiac rehabilitation on endothelial function and HbA1c in diabetic patients with Ischemic Heart disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015091924089N1

Enrollment

Registered

2015-12-02

Start date

2015-09-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease. Ischaemic heart diseases

Interventions

Intervention 1: Intervention: cardiac rehabilitation, which includes a period of 1 hour exercise, including warm-up period of about 10 minutes, then 40 minutes of exercise with a treadmill, stationary

Rehabilitation

Treatment - Drugs

Intervention: cardiac rehabilitation, which includes a period of 1 hour exercise, including warm-up period of about 10 minutes, then 40 minutes of exercise with a treadmill, stationary bike or exercis

The control group included patients with a history of Cardiovascular disease who are treated with anti- ischemic drugs.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diabetic patients treated with oral blood glucose lowering drugs, with history of CABG or PCI, they refer for Cardiac Rehabilitation Center of Imam Khomeini Hospital. Exclusion criteria: Smokers and those who have been smoking during the past 5 years are excluded? The reluctance of patients to participate in the study and not personal consent by the patient? Recurrent infarct during the study? Cardiovascular disorders and complications that require close care specialist such as severe ventricular arrhythmias and other serious complications? Treatment of diabetes with insulin?

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ankle Brachial Index. Timepoint: Before and after intervention. Method of measurement: By Vascular Screening Device VaSeraVS-1500N model.;HbA1C. Timepoint: Before and after intervention. Method of measurement: HbA1c blood and laboratory use.	—

Secondary

Measure	Time frame
METS. Timepoint: Before and after study. Method of measurement: The Duke questionnaire.;Fasting Blood Suger. Timepoint: Before and after study. Method of measurement: Blood Sample.;Blood Pressure. Timepoint: Before and after study. Method of measurement: By Manometer.;Glomerular filtration rate. Timepoint: Before and after study. Method of measurement: Cockcroft-Gault Equation.;Body Mass Index. Timepoint: Before and after study. Method of measurement: The ratio of height to weight.;Lipid Profil. Timepoint: Before and after study. Method of measurement: Blood Sample.	—

Measure

Time frame

METS. Timepoint: Before and after study. Method of measurement: The Duke questionnaire.;Fasting Blood Suger. Timepoint: Before and after study. Method of measurement: Blood Sample.;Blood Pressure. Timepoint: Before and after study. Method of measurement: By Manometer.;Glomerular filtration rate. Timepoint: Before and after study. Method of measurement: Cockcroft-Gault Equation.;Body Mass Index. Timepoint: Before and after study. Method of measurement: The ratio of height to weight.;Lipid Profil. Timepoint: Before and after study. Method of measurement: Blood Sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Mohammadirad

Ahvaz University of Medical Sciences

masoumemohammadirad@yahoo.com+98 61 4352 9921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026